Document is current
Any future updates will be listed below
-
Authors
Kim, Sheehyun
Lim, Yoojoo
Kang, Jun-Kyu
Kim, Hwang-Phill
Roh, Hanseong
Kim, Su Yeon
Lee, Dongin
Bang, Duhee
Jeong, Seung-Yong
Park, Kyu Joo
Han, Sae-Won
Kim, Tae-You https://orcid.org/0000-0002-9986-2684
-
Funding
Funding for this research was provided by:
Ministry of Health and Welfare (HI18C2282)
- License Information
-
More Information
Article History
Received: 8 November 2021
Revised: 25 April 2022
Accepted: 27 April 2022
First Online: 28 May 2022
Competing interests
: YL, J-KK, H-PK, HR and SYK are employees of IMBdx. DB has owned stock of IMBdx and Celemics. DB and S-WH have received research fund from IMBdx. T-YK is the founder of IMBdx. The remaining authors declare no competing interests.
: The study was conducted under the approval of the Institutional Review Board (IRB) of SNUH (IRB number: 1805-049-944) and in accordance with the Declaration of Helsinki in biomedical research involving human subjects. All participants provided written informed consent prior to any study procedures.
: Not applicable.
